EpigenCare
Farmingdale
About EpigenCare
EpigenCare is connecting consumers with skincare companies through a direct-to-consumer skincare test and web platform on the Ethereum network. Consumers receive actionable recommendations of optimized skincare products to use, as well as assess the progress of their skincare routines, based on their skin's epigenetic profiles. The recommendation engine looks at the functional state of a panel of epigenetic markers strongly correlated with skin quality indicators (e.g., aging, moisture retention, elasticity, etc.), and how skincare product ingredients affect them. It offers SKINTELLI, a direct-to-consumer personal epigenomics test that measures DNA methylation levels of a proprietary panel of genes responsible for key skin quality factors (e.g., aging, elasticity, moisture retention, etc.). The SKINTELLI web platform empowers you with the knowledge of which products truly work for your skin. EpigenCare was founded in 2017 and based in Farmingdale, New York.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $183.5K
- Last round: Equity Crowdfunding (Aug 2018)
- Website: epigencare.com
- Phone: [email protected]
Industries & Categories
Beauty, Biotechnology, Cosmetics, E-Commerce, Genetics
Social Profiles
Canonical: https://fsome.com/organization/epigencare-131245 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.